All cause‐mortality · cancer patients with afebrile neutropenia following chemotherapy
Summary of findings: quinolone prophylaxis probably leads to higher all cause‐mortality compared with TMP‐SMZ prophylaxis (moderate certainty).
1 finding from 1 review
Febrile patients and episodes · cancer patients with afebrile neutropenia following chemotherapy
Summary of findings: quinolone prophylaxis probably leads to lower febrile patients and episodes compared with TMP‐SMZ prophylaxis (moderate certainty).
1 finding from 1 review
Bacteraemia · cancer patients with afebrile neutropenia following chemotherapy
Summary of findings: quinolone prophylaxis probably leads to lower bacteraemia compared with TMP‐SMZ prophylaxis (moderate certainty).
1 finding from 1 review
Clinical diagnosis of leptospirosis regardless of laboratory confirmation · farmworkers
It is very uncertain whether summary of findings table ‐ Antibiotics changes clinical diagnosis of leptospirosis regardless of laboratory… compared with other antibiotics (very low certainty).
1 finding from 1 review
Laboratory‐confirmed leptospirosis · farmworkers
It is very uncertain whether summary of findings table ‐ Antibiotics changes clinical diagnosis of leptospirosis confirmed by laboratory diagnosis compared with other antibiotics (very low certainty).
2 findings from 1 review
Serious adverse events ‐ not reported · farmworkers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life ‐ not reported · farmworkers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Non‐serious adverse events · farmworkers
It is very uncertain whether summary of findings table ‐ Antibiotics changes non‐serious adverse events compared with other antibiotics (very low certainty).
1 finding from 1 review
All‐cause mortality ‐ not reported · farmworkers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Proportion of participants who were treated according to antibiotic prescribing guidelines · adults or children undergoing inpatient antibiotic prophylaxis or treatment
1 finding from 1 review
Intervention not reported
Duration of all antibiotic treatment · adults or children undergoing inpatient antibiotic prophylaxis or treatment
1 finding from 1 review
Preterm prelabour rupture of membranes · women in the second or third trimester of pregnancy before labour and delivery
Prophylactic antibiotics showed no clear difference in preterm prelabour rupture of membranes compared with placebo (low certainty).
1 finding from 1 review
Prelabour rupture of membranes · women in the second or third trimester of pregnancy before labour and delivery
Prophylactic antibiotics may leads to lower prelabour rupture of membranes compared with placebo (low certainty).
1 finding from 1 review
Preterm birth · women in the second or third trimester of pregnancy before labour and delivery
Prophylactic antibiotics showed no clear difference in preterm delivery compared with placebo (high certainty).
1 finding from 1 review
Chorioamnionitis · women in the second or third trimester of pregnancy before labour and delivery
It is very uncertain whether prophylactic antibiotics changes chorioamnionitis compared with placebo (very low certainty).
1 finding from 1 review
Puerperal sepsis/postpartum endometritis · women in the second or third trimester of pregnancy before labour and delivery
Prophylactic antibiotics probably leads to lower puerperal sepsis/postpartum endometritis compared with placebo (moderate certainty).
1 finding from 1 review
Overall mortality · adults receiving mechanical ventilation for at least 48 hours
Topical plus systemic prophylaxis leads to lower overall mortality compared with placebo or no treatment (high certainty).
1 finding from 1 review
Respiratory infections · adults receiving mechanical ventilation for at least 48 hours
Topical plus systemic prophylaxis probably leads to lower respiratory tract infections compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Dropouts due to adverse events · adults receiving mechanical ventilation for at least 48 hours
Topical plus systemic prophylaxis showed no clear difference in dropouts due to adverse events compared with placebo or no treatment (low certainty).
1 finding from 1 review
Gastrointestinal adverse events · adults receiving mechanical ventilation for at least 48 hours
Topical plus systemic prophylaxis showed no clear difference in gastrointestinal adverse events compared with placebo or no treatment (low certainty).
1 finding from 1 review